CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale
- RW Other RW
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 10-K/A Report 10-K/A
- 8-K Event Other events
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at an average $3.00 ($60,018)
- 8-K Event Results of operations
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 49 of 76 · 1,519 filings